 Connection
David Kao to Cardiomyopathies
This is a "connection" page, showing publications David Kao has written about Cardiomyopathies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.607 |
|
|
|
-
Davis MB, Jarvie J, Gambahaya E, Lindenfeld J, Kao D. Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model: PPCM Risk Prediction Model. J Card Fail. 2021 Feb; 27(2):159-167.
Score: 0.617
-
Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail. 2013 Oct; 1(5):409-16.
Score: 0.373
-
Kao DP, Witteles RM, Quon A, Wu JC, Gambhir SS, Fowler MB. Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy. J Am Coll Cardiol. 2010 Mar 02; 55(9):926-7.
Score: 0.291
-
Cooney R, Scott JR, Mahowald M, Langen E, Sharma G, Kao DP, Davis MB. Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy. Clin Cardiol. 2022 Feb; 45(2):205-213.
Score: 0.167
-
Doran B, Mei C, Varosy PD, Kao DP, Saxon LA, Feldman AM, DeMets D, Bristow MR. The Addition of a Defibrillator to?Resynchronization Therapy Decreases?Mortality in Patients With Nonischemic Cardiomyopathy. JACC Heart Fail. 2021 06; 9(6):439-449.
Score: 0.158
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|